Sat.Mar 06, 2021 - Fri.Mar 12, 2021

article thumbnail

Gilead’s HIV therapy Biktarvy demonstrates long-term sustained efficacy

Pharma Times

Data from two Phase III studies demonstrated durable viral suppression in HIV-1 patients

146
146
article thumbnail

EU probes low platelet safety issue with COVID-19 shots

pharmaphorum

EU regulators are reviewing reports of low blood platelets in patients who received any of the three approved COVID-19 vaccines from Pfizer/BioNTech, AstraZeneca and Moderna. The experts have also recommended a safety update on the label of Oxford University/AstraZeneca’s COVID-19 vaccine, which has been linked to anaphylactic reactions, in what has turned out to be a concerning week for vaccine safety.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Valneva and Pfizer start new Phase 2 study for Lyme disease vaccine candidate

Outsourcing Pharma

Valneva and Pfizer have initiated a Phase 2 study for their Lyme disease vaccine candidate: which is the only active Lyme disease vaccine in clinical development today.

Vaccines 138
article thumbnail

The drug Fenbendazole can make tumors sensitive to radiotherapy just like agents of chemotherapy

Pharma Mirror

Likewise, it was demonstrated by actualizing high throughput screening in-vitro framework that the drug fenbendazole is successful, not just against standard non-small cell lung cancer, NSCLC, yet in addition against the KRAS-mutant malignancy which seems, by all accounts, aggressive, barely accessible by chemotherapy and very normal (thirty percent of total cases of NSCLS) in people. [1] It became continually challenging in targeting KRAS transformation bearing tumors in view of the unclear con

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

EU approval for J&J’s single-shot COVID-19 vaccine

Pharma Times

Conditional marketing authorisation closely follows positive opinion from CHMP

Vaccines 137

More Trending

article thumbnail

Connecting Excipients with Drug Patents – New DrugPatentWatch module

Drug Patent Watch

New DrugPatentWatch module connects excipients and drug patents In response to user requests, DrugPatentWatch has added a new database of excipients (inactive ingredients) in drugs, and integrated it with our…. The post Connecting Excipients with Drug Patents – New DrugPatentWatch module appeared first on DrugPatentWatch - Make Better Decisions.

95
article thumbnail

Copado lands $96m in Series B funding to fuel life-sciences digital transformation

Outsourcing Pharma

The development technology firm plans to use the funds, sourced from a wide range of investors, to expand its dev-ops platform and expand its global reach.

73
article thumbnail

NHS England breast cancer wait times are ‘deeply worrying’

Pharma Times

All waiting time targets for breast cancer were missed in January

130
130
article thumbnail

Patient involvement in trial design: looking to the future

pharmaphorum

COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement. Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research. The pandemic has forced the industry to embrace virtual patient engagement to an extent that would have seemed unachievable little more than a year ago, but there is much more the industry needs to do to

132
132
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New patent for Blue Earth drug AXUMIN

Drug Patent Watch

Annual Drug Patent Expirations for AXUMIN Axumin is a drug marketed by Blue Earth and is included in one NDA. It is available from one supplier. There are five patents…. The post New patent for Blue Earth drug AXUMIN appeared first on DrugPatentWatch - Make Better Decisions.

91
article thumbnail

Medical Marijuana Is Not Regulated as Most Medicines Are

NY Times

The industry lacks randomized controlled clinical trials that can clearly establish benefits and risks.

73
article thumbnail

CQC publishes new agreement with Equality and Human Rights Commission

Pharma Times

Agreement aims to safeguard rights of people receiving health and social care in England

130
130
article thumbnail

EU regulators probe safety of AstraZeneca vaccine batch after blood clot reports

pharmaphorum

European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a precaution following reports of blood clots. Initial findings showed no issue with the shots suspended by Austrian authorities after a person was diagnosed with severe blood clotting and died 10 days after vaccination.

Vaccines 131
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Survey reveals site team thoughts about advanced technologies

Outsourcing Pharma

The DT Clinical Trial Digital Tracker Survey indicates many trial professionals often are hesitant to dive fully into digital technology integration.

72
article thumbnail

Nobody Wants Cancer. But a ‘Big C’ Label Has Surprising Upsides.

NY Times

Classifying a rare blood disorder as a cancer opened new doors for disease investigation, treatment and hope for a cure.

article thumbnail

New real-world evidence for Pfizer/BioNTech COVID-19 vaccine

Pharma Times

Evidence demonstrates lower incidence rates of COVID-19 in fully vaccinated individuals

Vaccines 130
article thumbnail

Why pharma isn’t yet achieving digital excellence, and how it can get there

pharmaphorum

Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods. To thrive in this environment, pharma needs to move from ad-hoc and reactionary digital transformation to long-term ‘digital excellence’, says Veeva’s Sebastien Noel. COVID has seen pharma sales experience three years’ worth of digital transformation in the space of just a few months – but while the industry has embraced digital tools and techniques, most companies are still far from

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Report reveals gap between rare-disease drug spending, need

Outsourcing Pharma

The IQVIA and NORD study shows rare-disease treatments account for only 11% of new drug spending, but 80% of orphan products treat rare diseases alone.

55
article thumbnail

European Countries Suspend Use of AstraZeneca Shots Over Worries About Blood Clots

NY Times

Millions of people have received the vaccine without safety problems, and there is no evidence of any causal link between the vaccine and blood clots.

article thumbnail

GSK to leverage the Cell and Gene Therapy Catapult’s facility in Stevenage

Pharma Times

British drugmaker to expand its clinical manufacturing capacity for cell and gene therapy

123
123
article thumbnail

Cambridge Sleep Sciences’ device is trialled in Parkinson’s

pharmaphorum

Sleep disturbances are a common feature for people with Parkinson’s disease, and a device developed to help people with insomnia is now being trialled to see if it can improve their sleep quality. . The SleepHub device – developed by Barkby group company Cambridge Sleep Sciences – is on the face of it a box and speakers that plays relaxing noises to help you fall asleep more easily, but is underpinned by a sound wave technology that its developer claims prompt the brain into the activity pattern

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs

Drug Patent Watch

This chart shows the companies which have received the most pediatric exclusivities in the past five years. Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their…. The post Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

As Covid Deaths Soar in Brazil, Bolsonaro Hails an Untested Nasal Spray

NY Times

Vaccines and critical-care beds are in short supply. Yet President Jair Bolsonaro is railing against social distancing and calling an experimental treatment from Israel “miraculous.”.

article thumbnail

Pharma, comms and patient group leaders join judging panel for Patient Partnership Index 2021

Pharma Times

Senior leaders from UK and European pharma have come together to judge the Patient Partnership Index 2021

123
123
article thumbnail

AI drug discovery firm Valence joins Parkinson’s disease push

pharmaphorum

Canada’s Valence Discovery has joined a University of Montreal-led project to try to find new drugs to treat the involuntary movement complications that can accompany treatments for Parkinson’s disease. . The go-to treatment for the five million people worldwide with Parkinson’s is levodopa, which replaces the activity of the dopamine neurotransmitter dopamine that gets depleted by the degeneration of nerve cells in the brain in the disease.

126
126
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19

Pharma Mirror

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVI

52
article thumbnail

Fred Figa, Who Helped Expose a Drug’s Dangers, Is Dead at 65

NY Times

He was the first hospital official to question the use of an unregulated vitamin injection linked to the deaths of 38 infants. He died of coronavirus complications.

article thumbnail

MHRA green light for DemeRx’s opioid use disorder trial

Pharma Times

Phase I portion of the trial will be conducted at the Manchester clinical unit of MAC Clinical Research

123
123